Novartis does not betray Switzerland. Despite the strength of the Swiss franc which reduces competitiveness and despite the popular vote against mass immigration which can create problems on the labor market, the multinational pharmaceutical industry and true jewel of Switzerland will not leave Basel. where it will maintain its registered office and headquarters.
It was the president of Novartis himself, Jorg Reinhardt, who cleared the field of Swiss rumors and fears with a clarifying interview with the Aargauer Zeitung.
Novartis shares gained 0,70% on the Zurich Stock Exchange yesterday.
